000			nab a22 7a 4500
999			_c15934 _d15934
003			PC15934
005			20210303114033.0
008			200521b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_9891 _aVanaclocha Sebastián, Francisco _eDermatología Médico Quirúrgica y Venereología
245	0	0	_aBody mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. _h[artículo]
260			_bJournal of the European Academy of Dermatology and Venereology : JEADV, _c2014
300			_a28(7):907-14.
500			_aFormato Vancouver: Carrascosa JM, Vilavella M, García-Doval I, Carretero G, Vanaclocha F, Daudén E et al; BIOBADADERM Study Group. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. J Eur Acad Dermatol Venereol. 2014 Jul;28(7):907-14.
501			_aPMID: 23848131
504			_aContiene 24 referencias
520			_aThere are few data on the prevalence of obesity in the general psoriasis population and on the real impact of obesity on the management of psoriasis patients in the clinical setting.
710			_9145 _aServicio de Dermatología Médico-Quirúrgica y Venereología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc15934.pdf _ySolicitar documento
942			_2ddc _cART _n0